or Try an Advanced Search...

    Acute Leukemia Stocks List

    Symbol Grade Name % Change
    SYRS D Syros Pharmaceuticals, Inc. -10.12
    BEAM F Beam Therapeutics Inc. 4.66
    KURA F Kura Oncology, Inc. 0.96
    INAB F IN8bio, Inc. 2.21
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Leukemia Acute Myeloid Leukemia Biotechnology Medicine Solid Tumors Acute Lymphoblastic Leukemia Antitrypsin Deficiency Benzamides Beta Thalassemia Biopharmaceutical Blood Cancers Carcinoma Cell Signaling Central Nervous System Disorders Clinical Medicine Disease Gene Therapy Glycogen Storage Disorder Immune Mediated Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Acute Leukemia stocks.

    Symbol Grade Name Weight
    ARKG D ARK Genomic Revolution Multi-Sector ETF 3.46
    GNOM F Global X Genomics & Biotechnology ETF 2.74
    IDNA C iShares Genomics Immunology and Healthcare ETF 1.89
    ARKK B ARK Innovation ETF 1.61
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 1.34
    View all Acute Leukemia ETFs...
    Compare ETFs
    Compare ARKG to ARKK Compare ARKK to BBC Compare GNOM to BBC

        Acute Leukemia Stocks Recent News

        Date Stock Title
        Nov 1 SYRS Syros Pharmaceuticals Inc (SYRS) Q3 2024 Earnings Call Highlights: Strategic Focus on ...
        Oct 31 SYRS Syros Pharmaceuticals, Inc (SYRS) Q3 2024 Earnings Call Transcript
        Oct 31 SYRS Syros Pharmaceuticals GAAP EPS of -$0.16 beats by $0.52
        Oct 31 SYRS Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update
        Oct 31 KURA Kura Oncology to Report Third Quarter 2024 Financial Results
        Oct 31 BEAM Beam Therapeutics (BEAM): Promising Gene Editing Stock with Base Editing Technology
        Oct 30 SYRS Syros Pharmaceuticals Q3 2024 Earnings Preview
        Oct 30 BEAM CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates
        Oct 29 BEAM Beam Therapeutics to Hold Conference Call to Discuss Third Quarter 2024 Financial Results and Abstracts Accepted for Presentation at ASH Annual Meeting
        Oct 28 BEAM We're Interested To See How Beam Therapeutics (NASDAQ:BEAM) Uses Its Cash Hoard To Grow
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Leukemia Acute Myeloid Leukemia Biotechnology Medicine Solid Tumors Acute Lymphoblastic Leukemia Antitrypsin Deficiency Benzamides Beta Thalassemia Biopharmaceutical Blood Cancers Carcinoma Cell Signaling Central Nervous System Disorders Clinical Medicine Disease Gene Therapy Glycogen Storage Disorder Immune Mediated Diseases
        Acute Leukemia

        Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original diagnosis of leukemia. In most cases, these can be classified according to the lineage, myeloid or lymphoid, of the malignant cells that grow uncontrolled, but some are mixed and for those such an assignment is not possible.Forms of acute leukemia include:

        Acute myeloid leukemia
        Acute erythroid leukemia
        Acute lymphoblastic leukemia
        T-cell acute lymphoblastic leukemia
        Adult T-cell leukemia/lymphoma
        (Precursor)T-lymphoblastic leukemia/lymphoma
        Blast crisis of chronic myelogenous leukemia

        More about Acute Leukemia
        Browse All Tags